Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Ashish Kamat Interview - BOND-003 Study Results

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Jan 09, 2024 1:18pm

190 Views

Post# 35817711

RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

I took the BOND-003 data, re-organized and added in the treatment schedule so you can appreciate that this is a treatment option but I agree wit Enrique - many pseudo CR results likely. See image below.

<a href='https://postimg.cc/4HQPcj3W' target='_blank'><img src='https://i.postimg.cc/4HQPcj3W/BOND-003-treatment-protocol-and-results.jpg' border='0' alt='BOND-003-treatment-protocol-and-results'/></a>

Direct link

https://i.postimg.cc/3NPcsTQQ/BOND-003-treatment-protocol-and-results.jpg

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario